Emergence ofCandida krusei infections after therapy of oropharyngeal candidiasis with fluconazole

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  1991-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01967286PMID 1915408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Failure of fluconazole therapy inCandida krusei fungemia

  1991cited by this paper
• Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.

  1990cited by this paper
• Bacteroides fragilis meningitis: report of two cases.

  1990cited by this paper
• Amphotericin B: current understanding of mechanisms of action

  1990cited by this paper
• Implications of the inoculum effect.

  1990cited by this paper
• Prophylaxis of oropharyngeal candidiasis with fluconazole.

  1990cited by this paper
• Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei

  1989cited by this paper

• Fruits are vehicles of drug-resistant pathogenic Candida tropicalis

  2023cites this paper
• Detection of Intrinsically Resistant Candida in Mixed Samples by MALDI TOF-MS and a Modified Naïve Bayesian Classifier

  2021cites this paper
• Infectious Complications of HIV Infection

  2018cites this paper
• Genetic Differentiation, Diversity, and Drug Susceptibility of Candida krusei

  2018cites this paper
• COMPARATIVE ANALYSIS OF PERCENTAGE INCIDENCE OF Candida ISOLATES IN SAMPLES OBTAINED FROM HOSPITAL AND COMMUNITY SETTINGS OF NIGER DELTA, NIGERIA

  2017cites this paper
• Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.

  2013cites this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

  2012cites this paper
• New staining methods for yeast like fungi under special consideration of human pathogenic fungi

  2010cites this paper
• Design, synthesis, antifungal activity, and ADME prediction of functional analogues of terbinafine

  2009cites this paper
• Susceptibilidade antifúngica, produção de biofilme e caracterização do gene ALS3 em isolados de Candida albicans e não-albicans do hospital das clínicas, UNESP, Botucatu

  2009cites this paper
• Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.

  2008cites this paper
• [Molecular typing of clinical Candida krusei isolates by using restriction endonuclease analysis of genomic DNA and polymerase chain reaction].

  2008cites this paper
• Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.

  2006cites this paper
• Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.

  2005influential citation
• Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients

  2005cites this paper
• The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan

  2005cites this paper
• Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan

  2005cites this paper
• Candidemia--an under-recognized nosocomial infection in Indian hospitals.

  2005cites this paper
• Susceptibilities of Candida Species to Amphotericin B and Fluconazole: The Emergence of Fluconazole Resistance in Candida tropicalis

  2004cites this paper
• Comparison of PCR- and HinfI Restriction Endonuclease-Based Methods for Typing of Candida krusei Isolates

  2004cites this paper
• Isolates Candida krusei ofEndonuclease-Based Methods for Typing Comparison of PCR-and HinfI Restriction

  2004cites this paper
• In Vitro susceptibility of 137 Candida sp. Isolates from HIV positive patients to several antifungal drugs

  2004cites this paper
• Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan.

  2003cites this paper
• Diagnosis and treatment of oropharyngeal candidiasis.

  2003cites this paper
• Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.

  2002cites this paper
• Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome.

  2001cites this paper
• Genomic diversity of oral Candida krusei isolates as revealed by DNA fingerprinting and electrophoreric karyotyping

  2000cites this paper
• Treatment of fungal infections in neutropenic children.

  1999cites this paper
• Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.

  1999cites this paper
• Diagnosis and Treatment of Oropharyngeal Candidiasis in Patients Infected with HIV: A Critical Reassessment

  1999cites this paper
• Nosocomial fungal infections: candidemia.

  1999cites this paper
• Comparative antimicrobial activity of an essential oil and an amine fluoride/stannous fluoride mouthrinse in vitro.

  1999cites this paper
• Clinical Perspective Oropharyngeal Candidiasis in Patients with HIV: Suggested Guidelines for Therapy

  1999cites this paper
• Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.

  1998cites this paper
• Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.

  1998cites this paper
• Update on Clinical Antifungal Susceptibility Testing for Candida Species

  1998cites this paper
• Candidemia: a nosocomial complication in adults with late-stage AIDS.

  1998cites this paper
• Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies.

  1998cites this paper
• In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates

  1997cites this paper
• [Amphotericin B deoxycholate (Fungizone): old drug, new versions].

  1997cites this paper
• T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations

  1997cites this paper
• Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients

  1997cites this paper
• [Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].

  1997cites this paper
• [Persistence and variability of yeasts isolated from hospitalized patients: a comparison of results from Rostock and Dresden].

  1997cites this paper
• [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].

  1997cites this paper
• Antifungal prophylaxis during neutropenia and immunodeficiency

  1997cites this paper
• Fluconazole susceptibility of Candida isolates from oropharyngeal candidosis

  1997cites this paper
• [Amphotericin B deoxycholate (Fungizone): old drug, new versions].

  1996cites this paper
• Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility

  1996cites this paper
• Antifungal agents: chemotherapeutic targets and immunologic strategies

  1996cites this paper
• Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua.

  1996cites this paper
• Oral manifestiations of pediatric human immunodeficeincy virus infection: a review of the literature.

  1996cites this paper
• Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission.

  1996cites this paper
• Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays

  1996cites this paper
• Patterns of opportunistic infections in patients with HIV infection.

  1996cites this paper
• Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.

  1996cites this paper
• Treatment and prevention of opportunistic infections in patients with human immunodeficiency virus infection.

  1996cites this paper
• Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

  1995cites this paper
• Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.

  1995cites this paper
• Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole

  1995cites this paper
• Mechanisms of resistance to azole antifungals.

  1995cites this paper
• Resistance of Candida species to fluconazole

  1995cites this paper
• Resistance to antifungal agents.

  1995cites this paper
• Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal.

  1995cites this paper
• Antifungal drug susceptibility testing. Working Party of the British Society for Antimicrobial chemotherapy.

  1995cites this paper
• Epidemiology of candidiasis.

  1995cites this paper
• Systemic mycoses in the 21st century.

  1995cites this paper
• Antifungal drugs and resistance.

  1995cites this paper
• Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome.

  1994cites this paper
• Fungal Sinusitis in Patients with AIDS: Report of 4 Cases and Review of the Literature

  1994cites this paper
• [Fluconazole sensitivity of Candida strains in vitro in the microdilution test and agar diffusion test].

  1994cites this paper
• In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus

  1994cites this paper
• Mechanisms and clinical impact of antifungal drug resistance.

  1994cites this paper
• Selection of Candida glabrata in pediatric bone marrow transplant recipients receiving fluconazole.

  1994cites this paper
• Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.

  1994cites this paper
• Cross‐sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro–in vivo correlation in HIV‐infected patients

  1994cites this paper
• Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard

  1994cites this paper
• Treatment of oral candidiasis in HIV infection.

  1994cites this paper
• Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen.

  1994cites this paper
• Treatment of invasive aspergillosis.

  1994cites this paper
• Antifungal susceptibility testing

  1993cites this paper
• Resistance of yeasts to azole-derivative antifungals.

  1993cites this paper
• Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts

  1993cites this paper
• Susceptibility testing of fungi: current status of the standardization process

  1993cites this paper
• Fungal infections in solid-organ transplantation.

  1993cites this paper
• In vitro and in vivo antifungal activities of D0870, a new triazole agent

  1993cites this paper
• Fluconazole resistance in Candida in patients with AIDS--a therapeutic approach.

  1993cites this paper
• Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1

  1993cites this paper
• In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts

  1993cites this paper
• Antifungal susceptibility testing. Current state of technology, limitations, and standardization.

  1993cites this paper
• Candida krusei sepsis in HIV infection.

  1992cites this paper
• Susceptibility of yeasts to fluconazole

  1992cites this paper
• Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients.

  1992cites this paper
• Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents

  1992cites this paper